Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec

Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec
aliu
Thu, 11/18/2021 – 11:24